ACADIA Pharmaceuticals (ACAD) Peer Comparison

$29.73

$0.15 (0.51%)

As on 27-Aug-2026 16:18EDT

Market cap

$5,051 Mln

Revenue (TTM)

$1,139 Mln

P/E Ratio

13

P/B Ratio

3.8

Div. Yield

0 %

Edit

	ACADIA Pharmaceuticals (ACAD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	5,051	16,614	17,326	13,400	12,305
Revenue ($ Mln)	1,139	1,054	2,782	2,436	670
Net Profit ($ Mln)	380.48	755.85	491.50	860.62	-319.95
Net Margin (%)	33.42	71.69	17.67	35.33	-47.79
RoE (%)	30.03	--	110.09	42.98	-71.14
Price to Earnings	13.00	19.38	36.49	17.01	--
Price-To-Book	3.83	10.05	39.43	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	ACADIA Pharmaceuticals (ACAD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	1,138.64	1,054.37	2,782.29	2,435.92	669.50
Cost of Revenue	100.98	103.47	1,982.07	85.67	19.14
Gross Profit	982.51	588.53	760.62	2,236.43	829.45
Operating Expenses	951.30	841.45	216.81	1,378.74	895.93
Operating Profit (EBIT)	86.37	109.45	583.40	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	121.37	101.11	598.92	1,035.47	-252.08
Provision for Tax	-259.12	-654.74	107.42	174.84	20.05
Profit after Tax (Net Income)	380.48	755.85	491.50	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	ACADIA Pharmaceuticals (ACAD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	1,306.61	1,435.90	433.86	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	74.86	384.48	187.89	288.55	1,362.63
Current Liabilities	361.44	464.70	1,435.43	361.93	283.35
Total Liabilities	1,564.20	1,302.02	1,975.47	2,844.42	1,385.30

Assets ($ Mln)

	ACADIA Pharmaceuticals (ACAD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	518.36	895.24	1,006.90	1,243.41	440.60
Current Assets	1,224.55	1,389.84	1,050.29	1,250.82	1,671.41
Total Assets	1,564.20	1,302.02	1,975.47	2,844.42	1,385.30
Total Debt*	73.85	449.89	120.10	165.93	864.07
Net Current Assets	863.11	0.00	-385.14	888.90	1,388.07

Cashflow ($ Mln)

	ACADIA Pharmaceuticals (ACAD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	109.84	51.77	713.22	884.27	179.55
Cash Flow from Investing Activities	-302.56	-8.15	-31.14	350.44	-129.29
Cash from Financing Activities	49.88	34.89	-860.39	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	ACADIA Pharmaceuticals (ACAD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	37.88	-30.01	53.56	32.82	-0.17
ROE (%)	30.03	163.18	110.09	42.98	-71.14
ROA (%)	20.79	26.53	15.64	29.32	-16.12
EBIT Margin (%)	9.14	5.73	21.13	31.04	-0.77
Net Margin (%)	33.42	71.69	17.67	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	ACADIA Pharmaceuticals (ACAD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	11.75	114.85	24.67	9.23	12.22
EBIT Growth (%)	-8.52	136.39	18.70	-3.99	93.17
Net Profit Growth (%)	71.27	378.76	17.50	42.89	-115.58
EPS Growth (%)	66.63	353.27	26.84	50.42	-73.87
Book Value Growth (%)	55.05	816.12	164.02	-0.70	-13.57

Valuation Ratios

	ACADIA Pharmaceuticals (ACAD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	11.71	-59.76	36.06	15.79	-2,869.63
Price / Book Value	3.73	-80.42	35.44	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	25.28	-121.54	28.08	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	ACADIA Pharmaceuticals (ACAD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.01	0.05	0.00	0.00	0.09
Current Ratio	3.39	2.99	0.73	3.46	5.90
Quick Ratio	3.30	2.32	0.73	3.38	5.90
Interest Coverage	--	1.62	--	--	-1.72

Operating Efficiency Ratios

	ACADIA Pharmaceuticals (ACAD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	14.61	21.25	15.88	13.74	1.28
Asset Turnover	0.62	0.37	0.89	0.83	0.34
Receivable days	43.11	85.52	50.42	43.48	1.50
Inventory Days	116.18	1,056.70	--	96.17	--
Payable days	55.60	331.01	6.26	147.97	221.81
Cash Conversion Cycle	103.69	811.21	--	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly